GLP-1 receptor agonists like Semaglutide and Tirzepatide have shown important cardiovascular Rewards, which include lessened possibility of main adverse cardiovascular gatherings (MACE) for example heart assault and stroke44. Consultation by using a Health care supplier is vital to ascertain the best option based upon person wellbeing needs